TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 150 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $49,905 | -31.7% | 3,249 | 0.0% | 0.01% | -36.4% |
| Q1 2023 | $73,070 | +6.9% | 3,249 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $68,326 | -1.0% | 3,249 | +16.4% | 0.01% | 0.0% |
| Q3 2022 | $69,000 | -9.2% | 2,792 | -11.2% | 0.01% | -8.3% |
| Q2 2022 | $76,000 | -6.2% | 3,143 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $81,000 | -23.6% | 3,143 | -8.2% | 0.01% | -15.4% |
| Q4 2021 | $106,000 | +27.7% | 3,424 | 0.0% | 0.01% | +18.2% |
| Q3 2021 | $83,000 | +66.0% | 3,424 | 0.0% | 0.01% | +57.1% |
| Q2 2021 | $50,000 | -20.6% | 3,424 | +34.8% | 0.01% | -22.2% |
| Q1 2021 | $63,000 | -7.4% | 2,541 | +2.3% | 0.01% | -18.2% |
| Q4 2020 | $68,000 | – | 2,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,028,875 | $25,351,000 | 8.34% |
| GREAT POINT PARTNERS LLC | 966,108 | $23,805,000 | 5.73% |
| Deep Track Capital, LP | 4,000,000 | $98,560,000 | 4.51% |
| RA Capital Management | 4,922,941 | $121,301,000 | 2.59% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $143,799,000 | 2.49% |
| Kynam Capital Management, LP | 416,729 | $10,268,000 | 2.16% |
| MPM BioImpact LLC | 276,460 | $6,812,000 | 1.61% |
| HighVista Strategies LLC | 110,698 | $2,728,000 | 1.56% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 186,019 | $4,582,000 | 1.47% |
| SECTORAL ASSET MANAGEMENT INC | 249,700 | $6,153,000 | 1.21% |